George Demetri is Director at Blueprint Medicines Corp (BPMC). They have made 9 open-market trades across 1 company since 2018, most recently 2022-06-21.
CIK 0001639147
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $827 since 2021, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BPMC | 8,412 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2022-06-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPMC | SELL | 2022-03-17 | 2022-06-30 | $58.56 | $586 | +10.7% | +1.1% | +35.7% |
| BPMC | BUY | 2021-07-13 | 2022-06-30 | $82.66 | $827 | +10.7% | +1.1% | +35.7% |
| BPMC | SELL | 2021-01-04 | 2021-01-06 | $112.15 | $170K | -1.8% | -2.2% | -7.0% |
| BPMC | SELL | 2020-09-22 | 2020-09-24 | $85.00 | $145K | +10.6% | +18.1% | +42.5% |
| BPMC | SELL · 10b5-1 | 2020-01-10 | 2020-01-14 | $85.00 | $48K | -15.2% | -17.2% | -17.1% |
| BPMC | SELL | 2020-01-07 | 2020-01-09 | $80.59 | $275K | -15.9% | -25.6% | -19.2% |
| BPMC | SELL | 2019-06-17 | 2019-06-19 | $97.99 | $167K | -1.1% | -0.3% | -17.4% |
| BPMC | SELL | 2019-06-13 | 2019-06-17 | $90.00 | $51K | -3.2% | +0.6% | -15.4% |
| BPMC | SELL | 2018-03-19 | 2018-03-21 | $100.07 | $809K | -10.3% | -17.5% | -30.0% |
| BPMC | SELL | 2018-02-27 | 2018-03-01 | $88.23 | $1.1M | +12.0% | -0.1% | -6.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.